Patent Reform Bill Is Resurrected; Senate Measure Mirrors Last Year's Compromise
Executive Summary
Members of the Senate Judiciary Committee are hoping that the patent reform bill that stalled in the last Congress will finally get enough traction to pass this year.
You may also be interested in...
Patent Bill Drama Moves To House As Senate Hands Brand Pharma Victory
With the Senate poised to approve its version of the patent reform bill, House Judiciary Committee Chairman Lamar Smith, R-Texas, will soon be in the driver's seat of a piece of legislation that could significantly alter the relationships pharmaceutical companies have with both their licensing partners and generic adversaries.
Patent Bill Drama Moves To House As Senate Hands Brand Pharma Victory
With the Senate poised to approve its version of the patent reform bill, House Judiciary Committee Chairman Lamar Smith, R-Texas, will soon be in the driver's seat of a piece of legislation that could significantly alter the relationships pharmaceutical companies have with both their licensing partners and generic adversaries.
Patent Bill Clears Senate Judiciary Cmte. Unanimously, But Floor Fight Looms
During markup the committee adopted an amendment to remove language that set a new standard for willful infringement; other provisions affecting the pharmaceutical industry remain intact.